WHG
CUE icon

Westwood Holdings Group’s Cue Biopharma CUE Stock Holding History

Westwood Holdings Group’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-750
Closed -$275K – 455
2021
Q1 		$275K Hold
750
– – ﹤0.01% 407
2020
Q4 		$281K Buy
750
+60
+9% +$24K ﹤0.01% 395
2020
Q3 		$312K Hold
690
– – ﹤0.01% 369
2020
Q2 		$507K Hold
690
– – 0.01% 356
2020
Q1 		$294K Hold
690
– – ﹤0.01% 371
2019
Q4 		$329K Buy
+690
New +$217K ﹤0.01% 415

Other funds holding CUE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Westwood Holdings Group's CUE Position: Q2 2021 in Review

Westwood Holdings Group sold out of Cue Biopharma (CUE) in Q2 2021, closing a stake of 750 shares — an estimated $275K sold.

Westwood Holdings Group first reported a position in CUE in Q4 2019 and held it in 6 quarters. The position peaked at $507K in Q2 2020. 89 funds tracked by Wall St. Rank hold CUE as of Q2 2021.

  • Westwood Holdings Group reported no remaining Cue Biopharma position as of Q2 2021 after selling out during the quarter.
  • Westwood Holdings Group sold 750 Cue Biopharma shares in Q2 2021, an estimated $275K.
  • Westwood Holdings Group first reported a position in Cue Biopharma in Q4 2019 and held it in 6 quarters.
  • Westwood Holdings Group's Cue Biopharma position peaked at $507K in Q2 2020.
  • 89 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2021.

Based on Westwood Holdings Group's 13F filing for Q2 2021, filed 16 Aug 2021.